nach oben

Erschienen in:

01.01.2007 | Original Paper

Similar CD19 Dysregulation in Two Autoantibody-Associated Autoimmune Diseases Suggests a Shared Mechanism of B-Cell Tolerance Loss

verfasst von: DONNA A. CULTON, MATILDA W. NICHOLAS, DONNA O. BUNCH, QUAN LI ZHEN, THOMAS B. KEPLER, MARY ANNE DOOLEY, CHANDRA MOHAN, PATRICK H. NACHMAN, STEPHEN H. CLARKE

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

We report here that dysregulation of CD19, a coreceptor that augments B-cell receptor (BCR) signaling, occurs at two B-cell differentiative stages in patients with systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic autoantibody (ANCA) associated small vessel vasculitis (SVV). The naïve B cells of nearly all SLE and ANCA-SVV patients express ∼20% less CD19 than healthy control (HC) B cells. In contrast, a subset of memory B cells of some SLE and ANCA-SVV Pts (25–35%) express two to fourfold more CD19 than HC B cells. These CD19^hi memory B cells are activated and exhibit evidence of antigen selection. Proteome array analysis of 67 autoantigens indicates that CD19^hi SLE Pts exhibit a distinct autoantibody profile characterized by high levels of antibodies to small nuclear ribonucleoproteins and low levels of antiglomerular autoantibodies. These findings have implications for autoreactive B-cell activation and suggest a shared mechanism of B-cell tolerance loss in these two diseases.

Hahn BH: Antibodies to DNA. N Engl J Med 338(19):1359, 1998PubMedCrossRef

Su W, Madaio MP: Recent advances in the pathogenesis of lupus nephritis: Autoantibodies and B cells. Semin Nephrol 23(6):564, 2003PubMedCrossRef

Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318(25):1651, 1988PubMedCrossRef

Jennette JC, Hoidal JR, Falk RJ: Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75(11):2263, 1990PubMed

Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135(5):921, 1989PubMed

Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 337(21):1512, 1997PubMedCrossRef

Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM: Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 56(220):467, 1985PubMed

Falk RJ, Hogan S, Carey TS, Jennette JC: Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 113(9):656, 1990PubMed

Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7(1):23, 1996PubMed

10.

Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271, 1982PubMed

11.

Blaese RM, Grayson J, Steinberg AD: Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med 69(3):345, 1980PubMedCrossRef

12.

Budman DR, Merchant EB, Steinberg AD, Doft B, Gershwin ME, Lizzio E, Reeves JP: Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum 20(3):829, 1977PubMed

13.

Suzuki H, Sakurami T, Imura H: Relationship between reduced B cell susceptibility to IgM antibodies and reduced IgD-bearing B cells in patients with systemic lupus erythematosus. Arthritis Rheum 25(12):1451, 1982PubMed

14.

Liossis SN, Kovacs B, Dennis G, Kammer GM, Tsokos GC: B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest 98(11):2549, 1996PubMedCrossRef

15.

Tsokos GC, Wong HK, Enyedy EJ, Nambiar MP: Immune cell signaling in lupus. Curr Opin Rheumatol 12(5):355, 2000PubMedCrossRef

16.

Bijl M, Horst G, Limburg PC, Kallenberg CG: Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 60(5):523, 2001PubMedCrossRef

17.

Folzenlogen D, Hofer MF, Leung DY, Freed JH, Newell MK: Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol 83(3):199, 1997PubMedCrossRef

18.

Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, Lipsky PE, Radbruch A, Dorner T: Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 165(10):5970, 2000PubMed

19.

Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, Valet G, Lipsky PE, Dorner T: Correlation between circulating CD27 high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 48(5):1332, 2003PubMedCrossRef

20.

Smith HR, Olson RR: CD5⁺ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 17(6):833, 1990PubMed

21.

Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF: CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 186(11):1923, 1997PubMedCrossRef

22.

Tedder TF, Inaoki M, Sato S: The CD19–CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6(2):107, 1997PubMedCrossRef

23.

Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF: The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149(9):2841, 1992PubMed

24.

Bradbury LE, Goldmacher VS, Tedder TF: The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13. J Immunol 151(6):2915, 1993PubMed

25.

Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT: C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 271(5247):348, 1996PubMedCrossRef

26.

Sato S, Hasegawa M, Fujimoto M, Tedder TF, Takehara K: Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 165(11):6635, 2000PubMed

27.

Sato S, Fujimoto M, Hasegawa M, Takehara K: Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 50(6):1918, 2004PubMedCrossRef

28.

Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, Peter HH, Warnatz K: A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol 113(2):161, 2004PubMedCrossRef

29.

Warnatz K, Wehr C, Drager R, Schmidt S, Eibel H, Schlesier M, Peter HH: Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology 206(5):502, 2002PubMedCrossRef

30.

Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630, 1992PubMed

31.

Matsuo T, Hisanaga S, Yamaguchi Y, Shimokawa H, Nakano H: [Case report of a prenatal diagnosis of 46, XY, t(13q; 14q) mat, +18]. Fukuoka Igaku Zasshi 79(12):927, 1988PubMed

32.

Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65(2):521, 2004PubMedCrossRef

33.

Borrero M, Clarke SH: Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1. J Immunol 168(1):13, 2002PubMed

34.

Arnold L, McCray S: Sequence analyses from single antigen-specific B lymphocytes using an mRNA capture plate. Am Biotechnol Lab 14, 2004

35.

Wang X, Stollar BD: Human immunoglobulin variable region gene analysis by single cell RT-PCR. J Immunol Methods 244(1–2):217, 2000PubMedCrossRef

36.

Volpe JM, Cowell LG, Kepler TB: SoDA: Implementation of a 3D alignment algorithm for inference of antigen receptor recombinations. Bioinformatics 22(4):438, 2006PubMedCrossRef

37.

Li QZ, Xie C, Wu T, Mackay M, Aranow C, Putterman C, Mohan C: Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 115(12):3428, 2005PubMedCrossRef

38.

Winn DM, Wolfe JF, Lindberg DA, Fristoe FH, Kingsland L, Sharp GC: Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen. Arthritis Rheum 22(12):1334, 1979PubMed

39.

Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM: Bm1–Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome. J Immunol 167(7):3610, 2001PubMed

40.

Fecteau JF, Cote G, Neron S: A new memory CD27-IgG+B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 177(6):3728, 2006PubMed

41.

Brezinschek HP, Brezinschek RI, Lipsky PE: Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 155(1):190, 1995PubMed

42.

Dorner T, Farner NL, Lipsky PE: Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation. J Immunol 163(2):1027, 1999PubMed

43.

Masilamani M, Kassahn D, Mikkat S, Glocker MO, Illges H: B cell activation leads to shedding of complement receptor type II (CR2/CD21). Eur J Immunol 33(9):2391, 2003PubMedCrossRef

44.

Ewert BH, Jennette JC, Falk RJ: Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 41(2):375, 1992PubMed

45.

Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110(7):955, 2002PubMedCrossRef

46.

Zandman-Goddard G, Shoenfeld Y: Infections and SLE. Autoimmunity 38(7):473, 2005PubMedCrossRef

47.

Qian Y, Santiago C, Borrero M, Tedder TF, Clarke SH: Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds. J Immunol 166(4):2412, 2001PubMed

48.

Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, Nussenzweig MC: Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 201(5):703, 2005PubMedCrossRef

49.

Ord DC, Edelhoff S, Dushkin H, Zhou LJ, Beier DR, Disteche C, Tedder TF: CD19 maps to a region of conservation between human chromosome 16 and mouse chromosome 7. Immunogenetics 39(5):322, 1994PubMedCrossRef

50.

Kuroki K, Tsuchiya N, Tsao BP, Grossman JM, Fukazawa T, Hagiwara K, Kano H, Takazoe M, Iwata T, Hashimoto H, Tokunaga K: Polymorphisms of human CD19 gene: Possible association with susceptibility to systemic lupus erythematosus in Japanese. Genes Immun 3(Suppl 1):S21, 2002PubMedCrossRef

51.

Tsuchiya N, Kuroki K, Fujimoto M, Murakami Y, Tedder TF, Tokunaga K, Takehara K, Sato S: Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis. Arthritis Rheum 50(12):4002, 2004PubMedCrossRef

52.

Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ: Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 202(2):321, 2005PubMedCrossRef

53.

Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ: Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25(3):417, 2006PubMedCrossRef

54.

Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV: TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 203(3):553, 2006PubMedCrossRef

55.

Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, Christensen SR, Shlomchik MJ, Viglianti GA, Rifkin IR, Marshak-Rothstein A: RNA-associated autoantigens activate B cells by combined B cell antigen receptor/toll-like receptor 7 engagement. J Exp Med 202(9):1171, 2005PubMedCrossRef

56.

Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 87(11):671, 1994

Titel: Similar CD19 Dysregulation in Two Autoantibody-Associated Autoimmune Diseases Suggests a Shared Mechanism of B-Cell Tolerance Loss
verfasst von: DONNA A. CULTON
MATILDA W. NICHOLAS
DONNA O. BUNCH
QUAN LI ZHEN
THOMAS B. KEPLER
MARY ANNE DOOLEY
CHANDRA MOHAN
PATRICK H. NACHMAN
STEPHEN H. CLARKE
Publikationsdatum: 01.01.2007
Verlag: Kluwer Academic Publishers-Plenum Publishers
Erschienen in: Journal of Clinical Immunology / Ausgabe 1/2007
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-006-9051-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Gene Polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in Exposed but Uninfected Partners of HIV-1 Infected Individuals in North India

The Expression of Retinoic Acid Receptors in Lymph Nodes of Young Children and the Effect of All-trans-Retinoic Acid on the B Cells from Lymph Nodes

Novel Analysis of Clonal Diversification in Blood B Cell and Bone Marrow Plasma Cell Clones in Immunoglobulin Light Chain Amyloidosis

Potent Systemic Antitumor Immunity Induced by Vaccination with Chemotactic-Prostate Tumor Associated Antigen Gene-Modified Tumor Cell and Blockade of B7-H1

“Spicing Up” of the Immune System by Curcumin